Chaur-Dong Hsu, MD, MPH, FACOG
Tamer A Gheita, MD
Professor of Rheumatology and Clinical Immunology

Education

 

Biography

Prof. Gheita is a distinguished Rheumatology consultant at many worldwide hospitals with Joint Commission International IJCI) accreditation. He has authored 100+ publications in top ranked international journals; coeditor of 10+ scientific books internationally published mostly in the field of Rheumatology; supervised on and discussed 25+ MD and MSc theses and was acknowledged by many of his colleagues for his guidance and help in their work. Has actively participated in 100+ regional and international conferences and is considered a notable speaker. Certificates of excellence were awarded for his effort in endorsing the practice of Rheumatology in regional countries, for his outstanding performance on attending many medical convoys and for sharing in lectures for junior MOH physicians all over Egypt. Prof. Gheita is a member of many specialized societies in the field of Rheumatology, Immunology, Osteoporosis and Orthopedics. He is a member of the Committee On Publication Ethics (COPE), Editorial Board Member of 20+ International Journals (such as the International J of Rheumatic Diseases, European J of Rheumatology, Annals of Pediatric Rheumatology, African J of Rheumatology and is on the review board of 60+ international journals in the field of Medicine, Rheumatology, Clinical Immunology and Pharmacology and reviewed the 6th edition of ‘Rheumatology’ textbook Elsevier. He shared in the scientific and organizing committee of several regional conferences. Attended and successfully passed the courses held by Faculty and Leadership Development center Program (FLDP), Cairo University recognized by the International Board of Certified Trainers (IBCT), The Netherlands. He holds the Platinum BMJ learning high-usage certificate, for successfully accomplishing rheumatology modules. He has acceptable computer skills (ICDL, UNESCO, USA).

Professor Gheita studied and attended his school in London, UK. He graduated from The Faculty of Medicine, Cairo University (December 1993) (Excellent with grade of Honors), attained the M.Sc degree (1997) with an excellent grade and successfully received his MD degree (2003). He is an active Rheumatology and Clinical Immunology Professor since 2013.

Research Interest

Rheumatology and Medical Orthopedics

 

Scientific Activities:

  • Professor of Rheumatology and Clinical Immunology, Faculty of Medicine, Cairo University
  • Member of the International Osteoporosis Foundation (IOF), Nyon, Switzerland
  • Editor In-Chief, The Egyptian Rheumatologist (Hosted and produced by Elsevier)
  • Certified EULAR Rheumatologist, Zürich, Switzerland (since 2012)

Publications

2015
  1. Gheita, T. A., GS Azkalany, S. A. Kenawy, and A. A. Kandeel, "Bone scintigraphy in axial seronegative spondyloarthritis patients: role in detection of subclinical peripheral arthritis and disease activity.", Int J Rheum Dis., issue doi: 10.1111/1756-185X.12527. [Epub ahead of print], 2015.
  2. Gheita, T. A., D. M. Abd-El-Rehim, S. A. Kenawy, and H. A. Gheita, "Clinical significance of MMP-3 in SLE patients: a potential biomarker for disease activity and damage.", Acta Reumatológica Portuguesa, issue Online First: 2015-01-12, 2015.
  3. Gheita, T. A., S. M. Gamal, I. Shaker, and et al, "Clinical significance of serum interleukin-23 and A/G gene (rs17375018) polymorphism in Behçets disease: Relation to neuro-Behçet, uveitis and disease activity.", Joint Bone Spine, vol. 82, issue 3, pp. 213-215, 2015.
  4. Gheita, T. A., GS Azkalany, W. Gaber, and A. Mohey, "Clinical significance of serum TNFα and -308 G/A promoter polymorphism in Rheumatoid Arthritis. ", The Egyptian Rheumatologist, vol. 37, issue 2, pp. 49-54, 2015.
  5. Gheita, T. A., H. M. Abdel-Samad, M. A. Mahdy, and A. B. Kamel, "Pattern of Primary Vasculitis with Peripheral Ischemic Manifestations: REPORT of a Case Series and Role of Vascular Surgery.", Curr Rheumatol Rev, vol. 10, issue 2, pp. 26-30, 2015.
  6. Gheita, T. A., A. M. N. Abdel-Baky, H. S. Assal, and et al, "Serum Cystatin C, UNGAL and NAG in juvenile and adult SLE; relation to clinical manifestations, disease activity and damage.", Saudi J Kidney Dis Transpl., issue Accepted fort publication, 2015.
  7. Gheita, T. A., S. Sayed, W. Hammam, and G. A. Hegazy, "Subclinical hypovitaminosis D and osteoporosis in breast cancer patients", Middle East J of Internal Medicine, vol. 8, issue 2, pp. 12-17, 2015.
2014
  1. Gheita, T. A., S. A. Kenawy, and H. A. Gheita, "BAFF in postmenopausal RA patients with low bone mass: A possible protective role of HCQ. ", Ann Rheum Dis. Supplement Paris, France, ‘EULAR’, 2014.
  2. Gheita, T. A., "Editorial: Gene therapy and rheumatic diseases: Back to the Future.", African J of Rheumatology,, vol. 2, issue 1, pp. 1-3, 2014.
  3. Gheita, T. A., I. I. El-Gazzar, H. S. El-Fishawy, and et al, "Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: Preliminary results. ", Clinical Rheumatology, vol. 33, issue 5, pp. 713-7, 2014.
  4. Gheita, T. A., and S. A. Kenawy, "Measurement of malondialdehyde, glutathione and glutathione peroxidase in systemic lupus erythematosus patients.", Systemic Lupus Erythematosus Methods and Protocols - Methods in Molecular Biology, NewYork, Springer - Humana Press, 2014.
  5. Gheita, T. A., H. Ammar, and S. A. Kenawy, "Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis.", SpringerPlus, vol. 3, pp. 559, 2014.
  6. Gheita, T. A., S. Sayed, W. Hammam, and G. A. Hegazy, "Subclinical hypovitaminosis D and osteoporosis in breast cancer patients. ", 7th Int’l Conf. on Osteoporosis and Bone Research (COBR), , Xiamen, China, 2014.
  7. Gheita, T. A., S. A. Kenawy, R. W. El-Sisi, and et al, "Subclinical reduced G6PD activity in RA and SS patients: relation to clinical characteristics, disease activity and MetS. ", Modern Rheum,, vol. 24, issue 4, pp. 612-617, 2014.
  8. Gheita, T. A., S. Sayed, GS Azkalany, and et al, "Subclinical sacroiliitis in brucellosis: Clinical presentation and MRI findings. ", Z Rheumatol., vol. 74, issue 3, pp. 240-245, 2014.
  9. Gheita, T. A., S. Sayed, and H. A. Gheita, "Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. ", Intl J Rheum Dis, issue doi: 10.1111/1756-185X.12426. [Epub ahead of print], 2014.
2013
  1. Gheita, T. A., R. W. El-Sisi, H. A. Raafat, and et al, "Anti-Annexin V Antibodies in Primary Fibromyalgia Syndrome: Relation to Associated Sjögren's Syndrome. ", J Clin Immunol., vol. 33, issue 2, pp. 311-3-12, 2013.
  2. Gheita, T. A., S. A. Kenawy, and R. W. El-Sisi, Behçet's disease and subclinical atherosclerosis: An overlooked association, , Berlin, Germany, LAP Lambert, 2013.
  3. Gaber, W., GS Azkalany, T. A. Gheita, and et al, "Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in Rheumatoid arthritis patients.", The Egyptian Rheumatologist,, vol. 35, issue 2, pp. 107-113, 2013.
  4. Gheita, T. A., I. I. El-Gazzar, R. I. El-Shazly, and et al, "Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity.", J Clin Immunol. , vol. 33, issue 1, pp. 297-301, 2013.
  5. Gheita, T. A., H. A. Raafat, S.Sayed, and et al, "Metabolic syndrome and insulin resistance comorbidity in SLE: effect on carotid intima-media thickness.", Zeitschrift fur Rheumatologie, vol. 72, issue 2, pp. 172-177, 2013.
  6. Gheita, T. A., H. Raafat, H. Khalil, and et al, "Serum level of APRIL/BLyS in Behҫet’s disease patients: clinical significance in uveitis and disease activity. Modern Rheumatology", Mod Rheumatol,, vol. 23, issue 3, pp. 542-546, 2013.
2012
  1. Cartilage Oligomeric Matrix Protein (COMP) in SSc: role in disease severity and subclinical RA overlap, Joint Bone Spine 2012;79(1):51-6, , 2012.
  2. Effectiveness of Nigella sativa oil in the management of Rheumatoid Arthritis patients: A placebo controlled study Phytotherapy, 2012;26(8):1246-8, , 2012.
  3. Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity Joint Bone Spine, 2012;79(3):285-90, , 2012.
  4. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis. 2012;15(3):261-7, , 2012.
  5. Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria. Clin Rheumatol. 2012;31(2):363-6, , 2012.
  6. Plasma concentrations of gas6 and the soluble form of its tyrosine kinase receptor Axl in patients with SLE and Behçets disease. J Clin Immunol. 2012;32(6):1279-86, , 2012.
  7. Serum TNFα and -308 G/A promoter polymorphism and Il-6 and -174 G/C promoter polymorphism in SLE patients.The Egyptian Rheumatologist ,2012,34(3);119-125, , 2012.
  8. Subclinical atherosclerosis in Behçet’s disease patients. Turk J Rheum,2012,27:109-114, , 2012.
  9. Temporomandibular joint osseous involvement in rheumatoid arthritis: clinical and Multislice computer tomographic features. A preliminary study. Turk J Rheum, 2012,27:47-55, , 2012.
2011
  1. Association of Tumor Necrosis Factor-Alpha Gene Polymorphisms with SLE nephritis in Egyptian Patients. Iran J Kidney Dis. 2011;5(6):392-7, , 2011.
  2. Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data. Rheumatology (Oxford). 2011;50(11):2108-12, , 2011.
  3. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis. 2011;14(4):325-31, , 2011.
  4. Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and systemic lupus erythematosus The Egyptian Rheumatologist,2011;33,45–51, , 2011.
  5. Shrinking lung syndrome in systemic lupus erythematosus patients; clinical characteristics, disease activity and damage. Int J Rheum Dis. 2011;14(4):361-8, , 2011.
  6. Transferring evidence from recent clinical rheumatology studies to those on the front lines. Int J Clin Pract.2011;65(9):1016, , 2011.
2010
  1. Differentiation of osteoporotic and neoplastic vertebral fractures by (in phase and out-of-phase) chemical shift MR imaging.Clinical Imaging.2010;34(2),162, , 2010.
  2. Musculoskeletal manifestations in patients with malignant disease. Clin Rheumatol. 29(2),2010,181-8, , 2010.
  3. Oxidant/Antioxidant status in patients with Behcet disease. Maced J Med Sci. 2010 15;3(1):37-42, , 2010.
2009
  1. Differentiation of osteoporotic and neoplastic vertebral fractures by (in phase and out-of-phase) chemical shift MR imaging. Eur J Radiol. 2009;72(1),125-133, , 2009.
  2. Myocardial perfusion scintigraphy (Gated-SPECT) and coronary disease risk factor in Behcet’s disease with metabolic syndrome. Medical J Cairo Univ. 2009,77(1),329-342, , 2009.
2008
  1. Involvement of IL-23 in psoriasis and psoriatic arthritis patients; possible role in pathogenesis. J Egypt Wom Dermatol Soc.2008;5(2),70-75, , 2008.
2007
  1. A case of polyarteritis nodosa complicated by left central retinal artery occlusion, ischemic optic neuropathy, and retinal vasculitis. Clin Rheumatol. 2007;26(5):814-6, , 2007.
  2. Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis. Clin Rheumatol. 2007;26(8):1393-5, , 2007.
  3. Hearing impairment in patients with Systemic Sclerosis and its relation to the clinical parameters of the disease. Medical J Cairo Univ. 2007;75(4)Suppl.III,13-25., , 2007.
  4. Hughes Stovin syndrome: Is it incomplete Behçet’s. Report of two cases and review of the literature. Clin Rheumatol. 2007;26(11):1993-6, , 2007.
  5. Multislice CT pulmonary findings in Behçet’s disease. (report of 16 cases). Clin Rheumatol 2007;26(6):879-84, , 2007.
  6. Pauciarticular severe destructive arthropathy in a child secondary to synovial osteochondromatosis. Clin Rheumatol. 2007;26(4):604-6, , 2007.
2006
  1. Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol. 2006;25(4):487-90., 2006.
  2. Successful treatment of extensive muscle calcification in a patient with primary idiopathic polymyositis with diltiazem. APLAR J Rheumatology, 2006;9(3):305-306, , 2006.

 

     
orthopedic-clinical-studies